◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

AURINIA PHARMACEUTICALS INC.

CIK: 1600620 SIC: 2834
$283.06M
Revenue
$287.20M
Net Income
88.46%
Gross Margin
37.06%
Op. Margin
$182.50M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 6 of 6 annual reports available (2020 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
+ Total Revenue $283.06M $283.06M $235.13M $175.51M $134.03M $45.60M $50.12M
Revenue Growth % 0.0% 20.4% 34.0% 31.0% 193.9% -9.0% nan%
Cost of Revenue $32.66M $32.66M $28.25M $14.15M $5.66M $1.09M -
+ Gross Profit $250.39M $250.39M $206.88M $161.37M $128.37M $44.51M $50.12M
Gross Margin % 88.5% 88.5% 88.0% 91.9% 95.8% 97.6% 100.0%
Operating Expenses $178.14M $178.14M $239.82M $267.20M $245.50M $226.34M $154.41M
Research & Development $32.51M $32.51M $20.79M $49.64M $44.99M $51.14M $50.33M
+ Operating Income $104.91M $104.91M $-4.69M $-91.69M $-111.47M $-180.74M $-104.29M
Operating Margin % 37.1% 37.1% -2.0% -52.2% -83.2% -396.3% -208.1%
Interest Expense $4.33M $4.33M $4.83M $2.77M - - -
Interest Income $13.57M $13.57M $16.97M $17.00M $5.12M - -
Income Before Tax $114.16M $114.16M $7.45M $-77.47M $-106.35M $-180.21M $-102.77M
Income Tax Expense $-173.04M $-173.04M $1.70M $551.00K $1.83M $760.00K $-94.00K
+ Net Income $287.20M $287.20M $5.75M $-78.02M $-108.18M $-180.97M $-102.68M
Net Margin % 101.5% 101.5% 2.4% -44.5% -80.7% -396.8% -204.9%
Basic EPS 2.14 2.14 0.04 -0.54 -0.76 -1.40 -0.87
Diluted EPS 2.07 2.07 0.04 -0.54 -0.76 -1.40 -0.87
Basic Shares Outstanding - 134.4M 143.1M 143.2M 141.9M 129.4M 118.5M
Diluted Shares Outstanding - 138.7M 146.2M 143.2M 141.9M 129.4M 118.5M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Cash & Cash Equivalents $80.16M $83.40M $48.76M $94.09M $231.64M $272.35M
Inventory $45.69M $39.23M $39.70M $24.75M $19.33M $13.93M
Other Current Assets $1.08M $1.13M $1.03M $1.33M $796.00K -
Total Current Assets $491.97M $446.60M $424.80M $442.54M $513.32M $419.43M
Property Plant & Equipment $2.11M $2.73M $3.35M $3.65M $4.42M $4.79M
Intangible Assets $3.76M $4.36M $4.98M $6.42M $8.40M $9.33M
Other Non-current Assets $93.00K $823.00K $1.52M $13.34M $11.84M $247.00K
Total Assets $751.59M $550.64M $548.06M $470.86M $543.37M $463.66M
Accounts Payable $3.31M $5.19M $4.33M - - -
Accrued Liabilities $66.62M $64.97M $50.06M - - -
Deferred Revenue $3.72M $11.00M $4.81M $3.15M $190.00K -
Other Current Liabilities $2.48M $1.53M $2.39M $2.03M $4.64M $6.12M
Total Current Liabilities $93.72M $97.76M $77.19M $46.11M $40.65M $32.00M
Other Non-current Liabilities $6.70M $11.11M $10.91M $12.17M $15.95M $1.59M
Total Liabilities $170.26M $173.17M $170.11M $65.42M $64.28M $55.91M
Retained Earnings $-649.37M $-936.57M $-942.32M $-864.30M $-756.12M $-575.16M
Total Stockholders Equity $581.33M $377.48M $377.95M $405.44M $479.09M $407.75M
Total Liabilities & Equity $751.59M $550.64M $548.06M $470.86M $543.37M $463.66M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Net Income $310.55M $287.20M $5.75M $-78.02M $-108.18M $-180.97M $-102.68M
Depreciation & Amortization $34.02M $19.45M $19.45M $11.65M $2.71M $2.76M $1.37M
Stock-based Compensation $13.30M $14.68M $31.60M $45.31M $32.30M $31.24M $17.45M
Deferred Income Tax - $-176.19M - - - - -
Change in Receivables $12.26M $4.91M $12.46M $10.61M $-1.93M $15.41M $650.00K
Change in Inventory $20.70M $6.46M $-477.00K $15.87M $9.07M $5.64M $13.93M
Change in Payables $-4.72M $-1.87M $860.00K $1.24M $-792.00K - -
Operating Cash Flow $182.50M $135.66M $44.39M $-33.46M $-79.53M $-157.69M $-69.86M
Purchases of Investments $856.05M $526.65M $545.83M $523.50M $523.99M $438.96M $202.95M
Investing Cash Flow $16.02M $-32.77M $39.26M $-6.71M $-60.63M $-103.87M $-158.19M
Stock Issued - $756.00K $1.08M - - $196.74M $187.73M
Stock Repurchased $234.56M $98.16M $40.24M - - - -
Financing Cash Flow $-249.18M $-106.11M $-49.09M $-5.13M $2.43M $221.11M $194.38M
Net Change in Cash $-50.66M $-3.22M $34.56M $-45.30M $-137.73M $-40.45M $-33.67M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $73.47M - $205.94M -
Cost of Revenue $8.18M - $23.87M -
Operating Expenses $43.72M - $134.27M -
Research & Development $8.44M - $21.61M -
Operating Income $29.75M - $71.67M -
Interest Expense $1.10M - $3.28M -
Interest Income $3.32M - $10.07M -
Income Before Tax $31.96M - $78.47M -
Income Tax Expense $411.00K - $2.06M -
Net Income $31.55M $722.00K $76.41M -
Basic EPS 0.24 - 0.57 -
Diluted EPS 0.23 - 0.55 -
Basic Shares Outstanding $131.81M - $135.16M -
Diluted Shares Outstanding $136.01M - $138.96M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $72.89M -
Inventory $44.79M $39.23M
Other Current Assets $301.00K $1.13M
Total Current Assets $438.74M $446.60M
Property Plant & Equipment $2.27M $2.73M
Intangible Assets $3.90M $4.36M
Other Non-current Assets $93.00K $823.00K
Total Assets $527.53M $550.64M
Accounts Payable $2.21M $5.19M
Accrued Liabilities $49.54M $64.97M
Deferred Revenue $4.60M $11.00M
Other Current Liabilities $2.50M $1.53M
Total Current Liabilities $76.22M $97.76M
Total Liabilities $161.76M $173.17M
Retained Earnings $-860.16M $-936.57M
Total Stockholders Equity $365.77M $377.48M
Total Liabilities & Equity $527.53M $550.64M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $31.55M $722.00K $76.41M -
Depreciation & Amortization - - $14.59M -
Stock-based Compensation - - $7.95M -
Change in Receivables - - $-5.82M -
Change in Inventory - - $5.57M -
Change in Payables - - $-2.97M -
Operating Cash Flow - - $89.99M -
Purchases of Investments - - $344.62M -
Investing Cash Flow - - $3.99M -
Stock Issued - - $401.00K -
Stock Repurchased - - $98.16M -
Financing Cash Flow - - $-104.22M -
Net Change in Cash - - $-10.24M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...